Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phillip Scott

Showing results (61-70 of 130) with videos related to

Pageof 13
Sort By:
BMC Infectious Diseases|November 12, 2013
Immunologic response and memory T cells in subjects cured of tegumentary leishmaniasisAugusto M Carvalho, Andréa Magalhães, Lucas P Carvalho, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 23, 2003
Cysteine protease B of Leishmania mexicana inhibits host Th1 responses and protective immunityLaurence U Buxbaum, Hubert Denise, Graham H Coombs, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 31, 2016
Leishmania major Infection-Induced VEGF-A/VEGFR-2 Signaling Promotes Lymphangiogenesis That Controls DiseaseTiffany Weinkopff, Christoph Konradt, David A Christian, et al.
Biorxiv : the Preprint Server for Biology|September 25, 2023
Sequentially activated death complexes regulate pyroptosis and IL-1β release in response to <i>Yersinia</i> blockade of immune signalingRonit Schwartz Wertman, Christina K Go, Benedikt S Saller, et al.
Vaccine|June 14, 2003
Efficacy of commercial and field-strain Mycobacterium paratuberculosis vaccinations with recombinant IL-12 in a bovine experimental infection modelJude E Uzonna, Paula Chilton, Robert H Whitlock, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2006
In vivo recognition of ovalbumin expressed by transgenic Leishmania is determined by its subcellular localizationSara Prickett, Peter M Gray, Sara L Colpitts, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2005
Cutting edge: a critical role for gene silencing in preventing excessive type 1 immunityAnne S Hutchins, David Artis, Brian D Hendrich, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 7, 2004
Cutting edge: early IL-4 production governs the requirement for IL-27-WSX-1 signaling in the development of protective Th1 cytokine responses following Leishmania major infectionDavid Artis, Leanne M Johnson, Karen Joyce, et al.
Infection and Immunity|June 3, 2009
Leishmania major phosphoglycans influence the host early immune response by modulating dendritic cell functionsDong Liu, Chahnaz Kebaier, Nazzy Pakpour, et al.
Stroke|June 6, 2009
Number needed to treat to benefit and to harm for intravenous tissue plasminogen activator therapy in the 3- to 4.5-hour window: joint outcome table analysis of the ECASS 3 trialJeffrey L Saver, Jeffrey Gornbein, James Grotta, et al.
Pageof 13

Showing results (61-70 of 130) with videos related to

Sort By:
Pageof 13
BMC Infectious Diseases|November 12, 2013
Immunologic response and memory T cells in subjects cured of tegumentary leishmaniasisAugusto M Carvalho, Andréa Magalhães, Lucas P Carvalho, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 23, 2003
Cysteine protease B of Leishmania mexicana inhibits host Th1 responses and protective immunityLaurence U Buxbaum, Hubert Denise, Graham H Coombs, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 31, 2016
Leishmania major Infection-Induced VEGF-A/VEGFR-2 Signaling Promotes Lymphangiogenesis That Controls DiseaseTiffany Weinkopff, Christoph Konradt, David A Christian, et al.
Biorxiv : the Preprint Server for Biology|September 25, 2023
Sequentially activated death complexes regulate pyroptosis and IL-1β release in response to <i>Yersinia</i> blockade of immune signalingRonit Schwartz Wertman, Christina K Go, Benedikt S Saller, et al.
Vaccine|June 14, 2003
Efficacy of commercial and field-strain Mycobacterium paratuberculosis vaccinations with recombinant IL-12 in a bovine experimental infection modelJude E Uzonna, Paula Chilton, Robert H Whitlock, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2006
In vivo recognition of ovalbumin expressed by transgenic Leishmania is determined by its subcellular localizationSara Prickett, Peter M Gray, Sara L Colpitts, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2005
Cutting edge: a critical role for gene silencing in preventing excessive type 1 immunityAnne S Hutchins, David Artis, Brian D Hendrich, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 7, 2004
Cutting edge: early IL-4 production governs the requirement for IL-27-WSX-1 signaling in the development of protective Th1 cytokine responses following Leishmania major infectionDavid Artis, Leanne M Johnson, Karen Joyce, et al.
Infection and Immunity|June 3, 2009
Leishmania major phosphoglycans influence the host early immune response by modulating dendritic cell functionsDong Liu, Chahnaz Kebaier, Nazzy Pakpour, et al.
Stroke|June 6, 2009
Number needed to treat to benefit and to harm for intravenous tissue plasminogen activator therapy in the 3- to 4.5-hour window: joint outcome table analysis of the ECASS 3 trialJeffrey L Saver, Jeffrey Gornbein, James Grotta, et al.
Pageof 13